Technical Analysis for CKPT - Checkpoint Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 2.99 -0.33% -0.01
CKPT closed down 0.33 percent on Tuesday, June 19, 2018, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CKPT trend table...

Date Alert Name Type % Chg
Jun 19 MACD Bearish Signal Line Cross Bearish 0.00%
Jun 19 New 52 Week Closing Low Bearish 0.00%
Jun 19 Stochastic Buy Signal Bullish 0.00%
Jun 19 Oversold Stochastic Weakness 0.00%
Jun 18 New 52 Week Closing Low Bearish -0.33%
Jun 18 Doji - Bullish? Reversal -0.33%
Jun 18 New 52 Week Low Weakness -0.33%
Jun 18 Earnings Movers Other -0.33%
Jun 18 Oversold Stochastic Weakness -0.33%
Jun 15 NR7 Range Contraction -3.24%

Older signals for CKPT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.
Is CKPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.5
52 Week Low 2.9
Average Volume 41,014
200-Day Moving Average 4.8033
50-Day Moving Average 3.4957
20-Day Moving Average 3.2005
10-Day Moving Average 3.095
Average True Range 0.2321
ADX 13.24
+DI 16.0
-DI 18.15
Chandelier Exit (Long, 3 ATRs ) 3.1237
Chandelier Exit (Short, 3 ATRs ) 3.5963
Upper Bollinger Band 3.5223
Lower Bollinger Band 2.8787
Percent B (%b) 0.17
BandWidth 20.109358
MACD Line -0.1352
MACD Signal Line -0.1343
MACD Histogram -0.0009
Fundamentals Value
Market Cap 75.85 Million
Num Shares 25.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -2.72
Price-to-Sales 75.20
Price-to-Book 6.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.32
Resistance 3 (R3) 3.34 3.26 3.27
Resistance 2 (R2) 3.26 3.17 3.25 3.25
Resistance 1 (R1) 3.12 3.12 3.08 3.10 3.23
Pivot Point 3.04 3.04 3.02 3.03 3.04
Support 1 (S1) 2.90 2.95 2.86 2.88 2.75
Support 2 (S2) 2.82 2.90 2.81 2.73
Support 3 (S3) 2.68 2.82 2.72
Support 4 (S4) 2.66